These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1132 related articles for article (PubMed ID: 21661712)
1. Diagnosis and management of community-acquired pneumonia in adults. Watkins RR; Lemonovich TL Am Fam Physician; 2011 Jun; 83(11):1299-306. PubMed ID: 21661712 [TBL] [Abstract][Full Text] [Related]
2. Community-Acquired Pneumonia in Adults: Diagnosis and Management. Kaysin A; Viera AJ Am Fam Physician; 2016 Nov; 94(9):698-706. PubMed ID: 27929242 [TBL] [Abstract][Full Text] [Related]
3. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit. Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787 [TBL] [Abstract][Full Text] [Related]
4. Current guidelines for the treatment of severe pneumonia and sepsis. Bodmann KF Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664 [TBL] [Abstract][Full Text] [Related]
5. Does empirical therapy with a fluoroquinolone or the combination of a β-lactam plus a macrolide result in better outcomes for patients admitted to the general ward? Ruhe J; Mildvan D Infect Dis Clin North Am; 2013 Mar; 27(1):115-32. PubMed ID: 23398869 [TBL] [Abstract][Full Text] [Related]
6. [Guidelines for treatment of pneumonia in intensive care units]. Emmi V Infez Med; 2005; Suppl():7-17. PubMed ID: 16801748 [TBL] [Abstract][Full Text] [Related]
7. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Charles PG; Whitby M; Fuller AJ; Stirling R; Wright AA; Korman TM; Holmes PW; Christiansen KJ; Waterer GW; Pierce RJ; Mayall BC; Armstrong JG; Catton MG; Nimmo GR; Johnson B; Hooy M; Grayson ML; Clin Infect Dis; 2008 May; 46(10):1513-21. PubMed ID: 18419484 [TBL] [Abstract][Full Text] [Related]
8. How Antibiotics Should be Prescribed to Hospitalized Elderly Patients with Community-Acquired Pneumonia. Arnold FW Drugs Aging; 2017 Jan; 34(1):13-20. PubMed ID: 27928779 [TBL] [Abstract][Full Text] [Related]
9. Moxifloxacin versus standard therapy in patients with pneumonia hospitalized after failure of preclinical anti-infective treatment. Wenisch C; Krause R; Széll M; Laferl H Infection; 2006 Aug; 34(4):190-5. PubMed ID: 16896576 [TBL] [Abstract][Full Text] [Related]
10. Monotherapy versus dual therapy for community-acquired pneumonia in hospitalized patients. Martinez FJ Clin Infect Dis; 2004 May; 38 Suppl 4():S328-40. PubMed ID: 15127366 [TBL] [Abstract][Full Text] [Related]
11. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis. Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274 [TBL] [Abstract][Full Text] [Related]
12. Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia. Teh B; Grayson ML; Johnson PD; Charles PG Clin Microbiol Infect; 2012 Apr; 18(4):E71-3. PubMed ID: 22284533 [TBL] [Abstract][Full Text] [Related]
13. Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting. Segreti J; House HR; Siegel RE Am J Med; 2005 Jul; 118 Suppl 7A():21S-28S. PubMed ID: 15993674 [TBL] [Abstract][Full Text] [Related]
14. [Factors effecting the duration of hospitalization and mortality in patients with community-acquired pneumonia]. Pişkin N; Aydemir H; Oztoprak N; Akduman D; Celebi G; Seremet Keskin A Mikrobiyol Bul; 2009 Oct; 43(4):597-606. PubMed ID: 20084912 [TBL] [Abstract][Full Text] [Related]
15. Community-acquired pneumonia: the U.S. perspective. Niederman MS Semin Respir Crit Care Med; 2009 Apr; 30(2):179-88. PubMed ID: 19296418 [TBL] [Abstract][Full Text] [Related]
16. Comparison of beta-lactam and macrolide combination therapy versus fluoroquinolone monotherapy in hospitalized Veterans Affairs patients with community-acquired pneumonia. Lodise TP; Kwa A; Cosler L; Gupta R; Smith RP Antimicrob Agents Chemother; 2007 Nov; 51(11):3977-82. PubMed ID: 17709460 [TBL] [Abstract][Full Text] [Related]
17. β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial. Garin N; Genné D; Carballo S; Chuard C; Eich G; Hugli O; Lamy O; Nendaz M; Petignat PA; Perneger T; Rutschmann O; Seravalli L; Harbarth S; Perrier A JAMA Intern Med; 2014 Dec; 174(12):1894-901. PubMed ID: 25286173 [TBL] [Abstract][Full Text] [Related]
19. Antibiotic treatment strategies for community-acquired pneumonia in adults. Postma DF; van Werkhoven CH; van Elden LJ; Thijsen SF; Hoepelman AI; Kluytmans JA; Boersma WG; Compaijen CJ; van der Wall E; Prins JM; Oosterheert JJ; Bonten MJ; N Engl J Med; 2015 Apr; 372(14):1312-23. PubMed ID: 25830421 [TBL] [Abstract][Full Text] [Related]
20. Adherence to infectious diseases society of America guidelines for empiric therapy for patients with community-acquired pneumonia in a commercially insured cohort. Wu JH; Howard DH; McGowan JE; Turpin RS; Henry Hu X Clin Ther; 2006 Sep; 28(9):1451-61. PubMed ID: 17062317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]